Labcorp's Q3 Earnings Looms: Here's What to Expect From the StockZacks Investment Research • 10/14/24
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis TestPRNewsWire • 10/10/24
LH Stock Likely to Gain From the Molecular Bioanalytical Lab ExpansionZacks Investment Research • 09/24/24
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum ExperiencePRNewsWire • 09/18/24
Labcorp Stock Gains From Its Latest Acquisition of BioReference HealthZacks Investment Research • 09/17/24
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034PRNewsWire • 09/16/24
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthPRNewsWire • 09/16/24
Labcorp Stock Gains From Market Expansion Efforts Amid Macro WoesZacks Investment Research • 09/12/24
LH Stock Expected to Gain From the Ballad Health Acquisition DealZacks Investment Research • 09/11/24
Xcell Biosciences Advances Labcorp Collaboration with Novel Platform for Automated Cell and Gene Therapy ManufacturingBusiness Wire • 09/10/24
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus DxPRNewsWire • 08/02/24